Data / Form D filings / Stemtrix Corp.
Stemtrix Corp.: Form D filing
Stemtrix Corp., a pharmaceuticals company in Dover, DE, filed a Form D with the SEC in 2023. The latest, on February 10, 2023, reports an offering of $20 million with nothing sold yet.
SpecStream is the live web data engine for teams and agents. It reads every Form D on SEC EDGAR the day it is filed, and this page is that reading. Ask for your own cut (a state, an industry, a size) and new filings arrive in your sheet, CRM, Slack or agent as they land.
Company details from the filing
- Address
- 8 THE GREEN, STE A, Dover, DE, 19901
- Phone
- (551) 587-7744
- Industry
- Pharmaceuticals
- Entity type
- Corporation
- Incorporated in
- Delaware
- Year incorporated
- 2023
- Revenue range
- No Revenues
- Exemptions claimed
- Rule 506(c)
- SEC identifier (CIK)
- 1965520
Form D filings
| Filed | Type | Offering | Sold | Remaining | Investors | First sale | Filing |
|---|---|---|---|---|---|---|---|
| Feb 10, 2023 | New notice | $20,000,000 | $0 | $20,000,000 | 0 | Yet to occur | sec.gov |
Executive officers and directors named in the filing
| Name | Role | Note in the filing |
|---|---|---|
| Evgenii Koluga | Executive Officer, Director |
Every Form D from the week of Feb 6, 2023 · All recent filings in Delaware · All recent Pharmaceuticals filings
Read from SEC EDGAR. Amount sold is what Stemtrix Corp. reported on the day it filed; on an offering that is still open, a later amendment can raise it. Free to reuse with credit to SpecStream under CC BY 4.0.